Deep Medicine Acquisition - Tradeable Rights - Oct 2026 OverviewDeep Medicine Acquisition - Tradeable Rights - Oct 2026 Profit Margin
Profitability ratio analysis for DMAQR.
Quarterly Profit Margin
-28.83%
↑ 41.82% YoY
As of Mar 2026
Annual Profit Margin (TTM)
-75.66%
↓ 65.53% YoY
Trailing 12 months ending Mar 2026
Average Profit Margin (Comparison Companies)
Profit Margin History
Profit Margin Comparison
Annual Profit Margin Growth Rate (%)